Prostate Cancer Therapy
Scientists at Shimane University, Department of Urology describe research in prostate cancer therapy
Published in Oncology Business Week, May 27th, 2007
Investigators publish new data in the report "Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer. To determine the safety and efficacy of combination chemotherapy with docetaxel (DTX), estramustine phosphate (EMP), and carboplatin (CBDCA) in patients with hormone-refractory prostate cancer (HRPC). This study included a total of 40 HRPC patients," scientists in Izumo, Japan report.
"We evaluated the activity of the following schedule: weekly DTX 30 mg/m2 iv, daily EMP 10mg/kg po, and CBDCA AUC=6 iv on day 1 of a every 4-wk cycle. Treatment was continued until disease progression or excessive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Bird Flu
ADVENTRX Pharmaceuticals Reports First Quarter 2007 Financial Results - Brain Cancer
Impact of Brain Tumors Leaves Many Patients Financially Destitute - Breast Cancer
BG Medicine Forms Research Collaboration with M.D. Anderson Cancer Center to Discover Serum Biomarkers for Breast Cancer Treatment Response - Breast Cancer
Computer-Aided Detection with Computed Radiography Effective in Detecting Breast Cancer - Breast Cancer
Five-Year Results of Cytyc's MammoSite Radiation Therapy System Presented at ASBS Annual Meeting - Breast Cancer
Fujifilm and the National Breast Cancer Foundation Provide Free Breast Cancer Screening As Part of Images of Health: Mammograms for a Million Moms Campaign - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
